These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)]. Lachmann D. Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315 [Abstract] [Full Text] [Related]
9. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Alaupovic P, Lee DM, McConathy WJ. Biochim Biophys Acta; 1972 Apr 18; 260(4):689-707. PubMed ID: 4337564 [No Abstract] [Full Text] [Related]
10. A method for the quantitative determination of the abnormal lipoprotein (LP X) of obstructive jaundice. Magnani HN, Alaupović P. Clin Chim Acta; 1972 May 18; 38(2):405-11. PubMed ID: 4337344 [No Abstract] [Full Text] [Related]
11. Biochemistry and clinical relevance of lipoprotein X. Narayanan S. Ann Clin Lab Sci; 1984 May 18; 14(5):371-4. PubMed ID: 6476782 [Abstract] [Full Text] [Related]
12. [An abnormal low-density lipoprotein in cholestases. I. Isolation and characterization]. Seidel D, Alaupovic P. Dtsch Med Wochenschr; 1970 Aug 28; 95(35):1774-80. PubMed ID: 4989048 [No Abstract] [Full Text] [Related]
13. Isolation and partial characterization of two abnormal human plasma lipoproteins: LP-X1 and LP-X2. Patsch JR, Patsch W, Sailer S, Braunsteiner H. Biochim Biophys Acta; 1976 Jun 15; 434(2):419-27. PubMed ID: 821525 [Abstract] [Full Text] [Related]
14. Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. Seidel D, Agostini B, Müller P. Biochim Biophys Acta; 1972 Jan 27; 260(1):146-52. PubMed ID: 4622266 [No Abstract] [Full Text] [Related]
15. Plasma lipoproteins in patients with familial plasma lecithin: cholesterol acyltransferase (LCAT) deficiency--studies on the apolipoprotein composition of isolated fractions with identification of LP-X. Seidel D, Gjone E, Blomhoff JP, Geisen HP. Horm Metab Res; 1974 Jan 27; Suppl 4():6-11. PubMed ID: 4371225 [No Abstract] [Full Text] [Related]
16. The isolation of lipoproteins from human plasma by ultracentrifugation in zonal rotors. Wilcox HG, Davis DC, Heimberg M. J Lipid Res; 1971 Mar 27; 12(2):160-72. PubMed ID: 4101815 [Abstract] [Full Text] [Related]
17. Radioimmunoassay of beta lipoprotein-protein of rat serum. Eaton RP, Kipnis DM. J Clin Invest; 1969 Aug 27; 48(8):1387-96. PubMed ID: 4978731 [Abstract] [Full Text] [Related]
18. Plasma lipoprotein changes in experimental cholestasis in the dog. Danielsson B, Ekman R, Johansson BG, Petersson BG. Clin Chim Acta; 1977 Oct 01; 80(1):157-70. PubMed ID: 198165 [Abstract] [Full Text] [Related]
19. Ultracentrifugal characterization of a lipoprotein occurring in obstructive jaundice. Mills GL, Seidel D, Alaupovic P. Clin Chim Acta; 1969 Nov 01; 26(2):239-44. PubMed ID: 4982019 [No Abstract] [Full Text] [Related]
20. Properties of the abnormal human plasma lipoprotein (LP-X) characteristic of cholestasis after chemical modification with succinic anhydride. Jonas A, Seidel D. Arch Biochem Biophys; 1974 Jul 01; 163(1):200-10. PubMed ID: 4369076 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]